Sulforaphane Inhibits IL-1β-Induced IL-6 by Suppressing ROS Production, AP-1, and STAT3 in Colorectal Cancer HT-29 Cells
Antioxidants · 28.03.2024 · 13 (4) · 406
DOI: 10.3390/antiox13040406 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 28.03.2024. Verfasst von Dhiraj Kumar Sah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Chonnam National University Medical School, Hwasun 58128, Republic of Korea. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Science, and Technology.
Abstract (Originalsprache)
Colorectal cancer (CRC) stands as a major cause of cancer-related mortality globally, accounting for approximately 881,000 deaths each year. Traditional approaches such as chemotherapy and surgery have been the primary treatment modalities, yet the outcomes for patients with metastatic CRC are often unsatisfactory. Recent research has focused on targeting the pathways involved in oxidative stress, inflammation, and metastasis to enhance the survival of CRC patients. Within this context, sulforaphane (SFN), a notable phytochemical found predominantly in cruciferous vegetables, has been recognized as a potential anticancer agent. However, the specific mechanisms through which SFN may exert its chemopreventive effects in CRC remain unclear. This study explores the impact of SFN on IL-1β-induced IL-6 activation and MAPK and AP-1 signaling in HT-29 cells. Our findings reveal that SFN treatment not only diminishes IL-1β-stimulated IL-6 expression but also reduces oxidative stress by curtailing reactive oxygen species (ROS) production. Furthermore, it hinders the proliferation and invasiveness of HT-29 cells through the modulation of MAPK/AP-1 and STAT3 signaling pathways. These results indicate that SFN mitigates IL-1β-induced IL-6 expression in CRC cells by attenuating ROS production and disrupting MAPK/AP-1 signaling. This suggests that SFN holds significant potential as a chemotherapeutic agent for both treating and preventing CRC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, Chonnam National University Medical School, Hwasun 58128, Republic of Korea.
- Department of Internal Medicine, Chonnam National University Medical School, Gwangju 501190, Republic of Korea.
ORCID-Profile: Dhiraj Kumar Sah, Archana Arjunan, Young Do Jung
Förderung
- Ministry of Education, Science, and Technology
Zitieren
APA
Sah, D. K., Arjunan, A., Park, S. Y., Lee, B., & Jung, Y. D. (2024). Sulforaphane Inhibits IL-1β-Induced IL-6 by Suppressing ROS Production, AP-1, and STAT3 in Colorectal Cancer HT-29 Cells. Antioxidants, 13(4), 406. https://doi.org/10.3390/antiox13040406
Vancouver
Sah DK, Arjunan A, Park SY, Lee B, Jung YD. Sulforaphane Inhibits IL-1β-Induced IL-6 by Suppressing ROS Production, AP-1, and STAT3 in Colorectal Cancer HT-29 Cells. Antioxidants. 2024;13(4):406. doi:10.3390/antiox13040406
BibTeX
@article{Sah2024,
author = {Sah, Dhiraj Kumar and Arjunan, Archana and Park, Seon Young and Lee, Bora and Jung, Young Do},
title = {Sulforaphane Inhibits IL-1β-Induced IL-6 by Suppressing ROS Production, AP-1, and STAT3 in Colorectal Cancer HT-29 Cells},
journal = {Antioxidants},
year = {2024},
volume = {13},
number = {4},
pages = {406},
doi = {10.3390/antiox13040406}
}
EUVIMED